metricas
covid
Annals of Hepatology ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS USING...
Journal Information
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
#179
Full text access
ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS USING THE PBC-27 QUESTIONNAIRE AT A TERTIARY CARE CENTER
Visits
139
Deborah Espinoza Lopez1, Rodrigo Toledo Galvan1, Maria Beatriz Jourdan Rodriguez1, Viridiana Lopez Ladron de Guevara1, Maria de Fatima Higuera de la Tijera1
1 Hospital General de México Dr. Eduardo Liceaga.
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 30. Issue S2

Abstracts of the 2025 Annual Meeting of the ALEH

More info
Introduction and Objectives

Primary biliary cholangitis (PBC) is a chronic liver disease that significantly impacts patients’ quality of life due to persistent symptoms like fatigue, pruritus, and emotional or cognitive disturbances. Understanding these effects is vital for guiding patient-centered care.

This study aimed to assess quality of life in patients with PBC using the validated PBC-27 questionnaire, identifying the most affected domains.

Materials and Methods

We conducted an cross-sectional, observational, and descriptive study in 50 adult patients with confirmed PBC, evaluated at a tertiary care center between March and May 2025. Variables included age, sex, comorbidities, disease duration, and PBC-27 domain-specific scores. Descriptive statistics were used, with medians and interquartile ranges for continuous variables, and absolute and relative frequencies for categorical data.

Results

All 50 patients completed the PBC-27 questionnaire. The mean overall score was 77.1 ± 4.2, ranging from 68.5 to 86.2. Fatigue was the most affected domain, with a mean score of 22.6 ± 3.2, followed by general symptoms (16.8 ± 2.9), pruritus (10.3 ± 2.1), and cognitive symptoms (8.9 ± 1.8). Emotional symptoms were also prevalent (8.7 ± 2.0). Domains related to dry mouth and dry eyes had the lowest impact, with mean scores of 5.3 ± 1.7 and 5.1 ± 1.5, respectively.

Conclusions

These findings underscore the multidimensional burden of PBC on quality of life, particularly in physical and neurocognitive domains. Regular assessment using structured tools like the PBC-27 is crucial for tailoring follow-up and improving patient outcomes.

Full Text

Conflict of interest: None

Chart 1. PBC-27 Questionnaire Results

Download PDF
Article options
Tools